TYCHEPharmaceuticals

Tyche Industries LtdCash Flow Statement

99.80
+0.00%

Tyche Industries Ltd Cash Flow Statement (Annual)

Metric20252024202320222021
Free Cash Flow7.82 Cr4.48 Cr4.68 Cr3.47 Cr
Capital Expenditure-0.72 Cr-3.23 Cr-1.75 Cr-0.99 Cr
End Cash Position84.26 Cr78.89 Cr69.28 Cr67.51 Cr
Beginning Cash Position78.89 Cr69.28 Cr67.51 Cr60.92 Cr
Changes In Cash5.37 Cr9.61 Cr1.77 Cr6.59 Cr
Financing Cash Flow-2.56 Cr-2.05 Cr-1.54 Cr-1.02 Cr
Cash Dividends Paid-2.56 Cr-2.05 Cr-1.54 Cr-1.02 Cr
Investing Cash Flow-0.62 Cr3.94 Cr-3.12 Cr3.16 Cr
Interest Received Cfi6.04 Cr5.05 Cr3.69 Cr3.04 Cr
Net Investment Purchase And Sale-5.96 Cr2.12 Cr-5.07 Cr
Purchase Of Investment-5.96 Cr-5.07 Cr
Net PPE Purchase And Sale-0.70 Cr-3.23 Cr-1.75 Cr-0.99 Cr
Sale Of PPE0.02 Cr0.000.00
Purchase Of PPE-0.72 Cr-3.23 Cr-1.75 Cr-0.99 Cr
Operating Cash Flow8.54 Cr7.71 Cr6.43 Cr4.46 Cr
Change In Working Capital0.18 Cr-1.13 Cr-5.60 Cr-3.49 Cr
Change In Other Current Liabilities1.35 Cr-1.10 Cr6.73 Cr0.64 Cr
Change In Other Current Assets-4.81 Cr5.64 Cr-7.35 Cr1.16 Cr
Change In Payable1.97 Cr-8.55 Cr6.48 Cr-0.98 Cr
Change In Receivables2.00 Cr2.96 Cr-5.66 Cr0.71 Cr
Other Non Cash Items-6.04 Cr-5.05 Cr-3.69 Cr-3.04 Cr
Deferred Tax-4.38 Cr-4.44 Cr-5.00 Cr-3.53 Cr
Depreciation And Amortization1.99 Cr1.94 Cr1.77 Cr1.79 Cr
Depreciation1.99 Cr1.94 Cr1.77 Cr1.79 Cr
Gain Loss On Investment Securities-0.02 Cr
Net Income From Continuing Operations16.82 Cr16.39 Cr18.95 Cr12.73 Cr
Other Cash Adjustment Outside Changein Cash-2000.001000.001000.001000.00
Common Stock Dividend Paid-2.05 Cr-1.54 Cr-1.02 Cr-1.02 Cr
Sale Of Investment2.12 Cr
Change In Inventory5.41 Cr-6.73 Cr-0.35 Cr-1.39 Cr
Issuance Of Debt0.000.000.00
Issuance Of Capital Stock0.000.000.00
Net Other Financing Charges-1.54 Cr-1.02 Cr-1.02 Cr
Net Common Stock Issuance0.000.000.00
Common Stock Issuance0.000.000.00
Net Issuance Payments Of Debt0.000.000.00
Net Short Term Debt Issuance0.000.000.00
Short Term Debt Issuance0.000.000.00
Net Other Investing Changes1.11 Cr
Taxes Refund Paid-0.12 Cr0.00
Gain Loss On Sale Of PPE0.00

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.